
Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

